Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

This is an early-stage study to test the safety and find the right dose of a new oral medication called FXS887 for adults with advanced solid tumors that have stopped responding to standard treatments. The trial will first test increasing doses in a small group of about 14 partic…